Le Lézard
Classified in: Health, Science and technology
Subject: PER

WW Appoints Doctor Adam Kaufman as Senior Vice President of Healthcare and Diabetes


NEW YORK, Feb. 26, 2021 /PRNewswire/ -- WW International, Inc. (NASDAQ: WW), a human-centric technology company powered by the world's leading commercial weight management program, announced today that Adam Kaufman, PhD has joined the company as Senior Vice President, Healthcare and Diabetes. In this role, Adam will manage WW Health Solutions, the existing business, and lead the development of a dedicated offering specifically designed for people with diabetes. He will sit on the senior leadership team and report to Nick Hotchkin, Chief Operating Officer.

"WW Health Solutions continues to be a key strategic growth lever for our business and we will now also focus on the broader healthcare market as well as diabetes as a core WW consumer offering," said Nick Hotchkin, WW Chief Operating Officer. "We are thrilled to have Adam join the team. In addition to his deep expertise in diabetes, he has unique experience in applying technology to improvements in healthcare services."

Adam comes to WW from DTxL - Boston Consulting Group's and Abundant Venture Partners' joint venture - where he led its launch as a leader in digital therapeutics. Prior to that, Adam spent five years at Canary Health where he oversaw the launch of a new online business offering and mobile technology enabled healthcare services. Prior to Canary Health, Adam served in leadership roles at healthcare institutions including DPS Health where he was President & CEO and at dLife where he was General Manager and Executive Vice President.

"I am excited to join the WW team to lead these important growth initiatives and extend support through the healthcare ecosystem," said Adam Kaufman. "In the U.S. alone, more than 30 million people are living with diabetes. Despite the high correlation between obesity and Type 2 diabetes, the population is under-represented within the WW community. I am looking forward to applying my experience and knowledge to further scale our impact and advancing our relationships with employers, providers, payors and physicians."

About WW International, Inc.
WW (formerly Weight Watchers) is a human-centric technology company powered by the world's leading commercial weight management program. As a global wellness company, we inspire millions of people to adopt healthy habits for real life. Through our comprehensive digital app, expert Coaches and engaging experiences, members follow our proven, sustainable, science-based program focused on food, activity, mindset and sleep. Leveraging nearly six decades of expertise in nutritional and behavioral change science, providing real human connection and building inspired communities, our purpose is to democratize and deliver holistic wellness for all. To learn more about the WW approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com

About WW Health Solutions
WW Health Solutions partners with employers, payors and health providers to implement wellness and weight management tools. WW Health Solutions aims to propel happier, healthier, more productive workplaces and make wellness more accessible. WW Health Solutions supports partners, including Fortune 500 companies, that span industries such as healthcare, government, education and manufacturing.

For more information, contact:
Nicole Penn, WW
VP Corporate Communications
917.734.0802
[email protected]

SOURCE WW International, Inc.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: